98%
921
2 minutes
20
Objectives: CANWARD is a Canadian Antimicrobial Resistance Alliance (CARA)/Health Canada partnered national surveillance study established in 2007 to annually assess the in vitro activities of commonly tested and recently approved antimicrobial agents for bacterial pathogens isolated from patients receiving care in Canadian hospitals.
Methods: In total, 34 155 Gram-negative pathogens were tested using the CLSI reference broth microdilution method.
Results: In total, 39.4%, 37.1%, 17.7% and 5.8% of isolates tested were from respiratory, blood, urine and wound specimens, respectively; 31.1%, 23.9%, 19.0%, 18.5% and 7.5% of isolates were from patients in medical wards, emergency rooms, ICUs, hospital clinics and surgical wards. In total, 51.8% of isolates were from male patients; and 10.1%, 40.7% and 49.2% of isolates were from patients aged ≤17, 18-64 and ≥65 years. The most common Gram-negative pathogens received were: Escherichia coli (34.9%), Pseudomonas aeruginosa (17.5%) and Klebsiella pneumoniae (11.6%). An ESBL-producing phenotype was identified in 8.4% of E. coli and 5.6% of K. pneumoniae isolates. Percent susceptible values for E. coli included: 100% for meropenem/vaborbactam and imipenem/relebactam; >99% for ceftazidime/avibactam, meropenem and ceftolozane/tazobactam; 95.6% for piperacillin/tazobactam; and 73.9% for ciprofloxacin. Percent susceptible values for K. pneumoniae included: >99% for meropenem/vaborbactam, imipenem/relebactam, ceftazidime/avibactam and meropenem; 97.4% for ceftolozane/tazobactam; 91.9% for piperacillin/tazobactam; and 87.0% for ciprofloxacin. Percent susceptible values for P. aeruginosa included: 96.6% for ceftolozane/tazobactam; 92.6% for ceftazidime/avibactam; 92.0% for imipenem/relebactam; 79.9% for piperacillin/tazobactam; ceftazidime 78.1%; 78.0% for meropenem; and 68.6% for ciprofloxacin.
Conclusions: The CANWARD surveillance study has provided 17 years of reference antimicrobial susceptibility testing data.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/jac/dkaf217 | DOI Listing |
J Extracell Vesicles
September 2025
IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Toulouse, France.
Outer membrane vesicles (OMVs) are nanosized vesicles naturally secreted by Gram-negative bacteria and represent a promising platform for vaccine development. OMVs possess inherent immunostimulatory properties due to the presence of pathogen-associated molecular patterns (PAMPs), providing self-adjuvanting capabilities and the ability to elicit both innate and adaptive immune responses. This review outlines the advantages of OMVs over traditional vaccine strategies, including their safety, modularity, and the potential for genetic engineering to enable targeted antigen delivery.
View Article and Find Full Text PDFACS Nano
September 2025
State Key Laboratory of Materials-Oriented Chemical Engineering, National Engineering Research Center for Special Separation Membrane, Nanjing Tech University, Nanjing 210009, China.
Airborne pathogens and pollution control typically necessitate multiple membranes, each specializing in efficient aerosol filtration, moisture regulation, or antimicrobial protection. Integrating all these functions into a single membrane is highly advantageous but remains inherently challenging due to material incompatibility and inevitable performance trade-offs. Here, we present a photoactive Janus nanofibrous membrane for highly efficient air purification, engineered via sequential electrospinning.
View Article and Find Full Text PDFCureus
August 2025
Neurological Surgery, Punjab Institute of Neurosciences, Lahore, PAK.
Brain abscesses are life-threatening infections, predominantly caused by anaerobic organisms. The role of oropharyngeal microbiota, presence in dental plaque biofilms, and hematogenous spread is established in the literature. However, due to its rare occurrence, limited literature is available on its management.
View Article and Find Full Text PDFBiosaf Health
August 2025
Departamento de Especialidades Médicas, Instituto Nacional de Enfermedades Neoplásicas, Surquillo 15038, Perú.
Healthcare-associated infections are linked with the contamination of inanimate surfaces and the air in occupied hospital areas by recognized pathogens. However, there is limited information about the presence of these microorganisms or other potential pathogens in critical areas prior to their clinical operation. Here, we determined the microbial community in critical areas prior to their validation for hospital care and reviewed the background for the potential pathogenic role of this microbiota for populations susceptible to opportunistic infections.
View Article and Find Full Text PDFFront Immunol
September 2025
College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology, Xinxiang, China.
Introduction: Galectin-9 is a β-galactoside-binding lectin that functions as a critical pattern recognition receptor (PRR) in the host immune system, initiating immune defense responses by recognizing and binding to pathogen-associated molecular patterns (PAMPs) on the surface of microorganisms. In this study, we identified and characterized a novel galectin-9 cDNA, designated CcGal-9, from Yellow River carp ().
Methods: The full-length CcGal-9 cDNA was cloned and sequenced, and its structural features were analyzed.